Centerline Biomedical, Inc. — Form D
Centerline Biomedical, Inc. of Warrensville Heights, OH, a company, filed a Form D exempt-offering notice with the SEC on 2023-11-03. The offering totals $13.7M, of which $13.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-11-03
- Form: D
- Accession: 0001998847-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $13.7M
- Amount sold: $13.7M
- Investors: 65
- Date of first sale: 2015-08-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-496436
Issuer
- Name: Centerline Biomedical, Inc.
- CIK: 0001998847
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 4535 Renaissance Parkway, Warrensville Heights, OH, 44128
- Phone: 216-445-0830
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Karen Shanahan | Director | Cleveland, OH |
| Jim N Zalar | Director | Cleveland, OH |
| Jai N Gupta | Executive Officer | Cleveland, OH |
| Michael Whitman | Director | Newtown, PA |
| Todd Schwarzinger | Director | Warrensville Heights, OH |
| Mitch Wolf | Director | Warrensville Heights, OH |
| Gulam Khan | Director | Warrensville Heights, OH |
| Gulam Khan | Executive Officer | Warrensville Heights, OH |
| Arnaud Marie | Director | Warrensville Heights, OH |
| Indrani Egleston | Executive Officer | Warrensville Heights, OH |
| Vikash K Goel | Executive Officer | Cleveland, OH |
| Vinod K Goel | Director | Cleveland, OH |
| Vinod K Goel | Executive Officer | Cleveland, OH |
| Akhil Saklecha | Director | Cleveland, OH |
| Phil Rackliffe | Director | Cleveland, OH |
| Phil Rackliffe | Executive Officer | Cleveland, OH |
| Phil N Rackliffe | Director | Cleveland, OH |
| Phil N Rackliffe | Executive Officer | Cleveland, OH |
| Vikash N Goel | Executive Officer | Cleveland, OH |
| Jai N Gupta | Director | Cleveland, OH |
| Jim Zalar | Director | Cleveland, OH |
Other filings by this issuer (3)
More